The results demonstrate a complex interplay with IL4I1 being shown as a prognostic and important factor in HNSCC, laying the foundation for further studies into analyzing the impact of dual therapy of these markers in vitro for HNSCC. The gene discussed is IL4I1; the disease is head and neck squamous cell carcinoma.